Related Experiment Video
Updated: May 28, 2026

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice
Published on: February 16, 2024
Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line
Cécile Ménez1, Laïla Mselli-Lakhal, Magali Foucaud-Vignault
1INRA UMR1331, Université de Toulouse, INP, TOXALIM, Toulouse, F-31027, France. cecile.menez@toulouse.inra.fr
Abstract:
Ivermectin is widely used in human and veterinary medicine for the control of helminth infections. Ivermectin is known to interact with P-glycoprotein (P-gp/MDR1), being a good substrate and a potent inhibitor, however, the influence of ivermectin on the expression of the transporter has not been investigated. Expression of P-glycoprotein was investigated in cultured mouse hepatocytes acutely exposed to ivermectin. The two P-glycoprotein murine isoforms, Mdr1a and Mdr1b, mRNA levels were assessed by real-time RT-PCR. Ivermectin induced a clear time- and concentration-dependent up-regulation of Mdr1a and Mdr1b mRNA levels (as early as a 12-h exposure and up to 2.5-fold at 10μM). Moreover, ivermectin-treated cells displayed enhanced cellular efflux of the P-glycoprotein substrate calcein that was inhibited by the P-glycoprotein blocker valspodar, providing evidence that the ivermectin-induced P-glycoprotein was functional. The mechanisms underlying these effects were investigated. Ivermectin-mediated Mdr1 mRNA induction was independent of the two nuclear receptors CAR and PXR, which are known to be involved in drug transporters regulation. Moreover, by using reporter cell lines that detects specific ligand-activated transcription factors, we showed that ivermectin did not displayed CAR, PXR or AhR ligand activities. However, studies with actinomycin D revealed that the half-life of Mdr1a and Mdr1b mRNA were significantly prolonged by two-fold in ivermectin-treated cells suggesting a post-transcriptional mode of ivermectin regulation. This study demonstrates for the first time that ivermectin induces P-glycoprotein overexpression through post-transcriptional mRNA stabilization, thus offering insight into the mechanism of reduced therapeutic efficacy and development of ivermectin-resistant parasites.
Insights
Ivermectin increases the expression of P-glycoprotein (P-gp/MDR1) in liver cells by stabilizing its mRNA. This functional P-gp overexpression may explain reduced drug efficacy and parasite resistance to ivermectin.
Area of Science:
- Pharmacology
- Molecular Biology
- Drug Metabolism
Background:
- Ivermectin is a crucial antiparasitic drug used in human and veterinary medicine.
- Ivermectin is known to interact with P-glycoprotein (P-gp/MDR1), a key drug transporter.
- The effect of ivermectin on P-gp expression levels was previously uninvestigated.
Purpose of the Study:
- To investigate the influence of ivermectin on P-glycoprotein (P-gp/MDR1) expression in mouse hepatocytes.
- To elucidate the molecular mechanisms underlying ivermectin-induced changes in P-gp expression.
Main Methods:
- Primary mouse hepatocytes were exposed to ivermectin.
- Messenger RNA (mRNA) levels of P-gp isoforms (Mdr1a, Mdr1b) were quantified using real-time RT-PCR.
- Cellular efflux of the P-gp substrate calcein was measured.
- Reporter cell lines were used to assess ligand activities of nuclear receptors.
- Actinomycin D was employed to determine mRNA half-life.
Main Results:
- Ivermectin caused a time- and concentration-dependent upregulation of Mdr1a and Mdr1b mRNA.
- Ivermectin treatment enhanced the efflux of calcein, indicating functional P-gp.
- The induction of Mdr1 mRNA by ivermectin was independent of CAR and PXR nuclear receptors.
- Ivermectin prolonged the half-life of Mdr1a and Mdr1b mRNA, suggesting post-transcriptional regulation.
Conclusions:
- Ivermectin induces P-glycoprotein (P-gp/MDR1) overexpression in hepatocytes.
- This overexpression occurs via post-transcriptional stabilization of Mdr1 mRNA.
- The findings provide insights into mechanisms of reduced ivermectin efficacy and parasite resistance.
Related Concept Videos
Abnormal Proliferation
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

